Psychopharmacology: Drugs of Pharmacotherapy and Addiction
Edition: 1
Copyright: 2022
Pages: 370
Choose Your Format
Choose Your Platform | Help Me Choose
Ebook
$82.69
Psychopharmacology: Drugs of Pharmacotherapy and Addiction is divided into three parts. Part 1 covers neurology and drug research. Topics include neurobiology, pharmacokinetics and pharmacodynamics, and how drugs are approved and regulated for pharmacotherapy. Part 2 includes chapters on psychological disorders (e.g., depression, schizophrenia) and the drugs used to treat those disorders. The chapters in Part 2 include discussion of each diagnosis, prevalence rates of the disorders, research on genetics and heritability, a review of the history of drugs used to treat the disorders, and current drugs used in treatment. Part 3 covers common drugs of addiction, including brief histories on the drug’s uses, prevalence rates, effects on health and behavior, pharmacokinetics and pharmacodynamics, and treatment for drug use disorders. With the ever-changing landscape of medications for psychological disorders, the book also examines future directions in drug development, notably the emergence of psilocybin and other hallucinogens in the treatment of anxiety and depression. This book also contains numerous links to documents and videos that give further explanation to topics or illustrate issues involved in psychological disorders and drugs, such as people discussing their experiences with different psychiatric disorders or use of drugs.
Part 1 Neurology and Drug Research
Chapter 1 Neurobiology
Chapter 2 Pharmacokinetics and Pharmacodynamics
Chapter 3 Drug Approval and Regulation
Part 2 Psychiatric Disorders and Pharmacotherapy
Chapter 4 Childhood Disorders
Chapter 5 Depression and Antidepressants
Chapter 6 Bipolar Disorders and Mood Stabilizers
Chapter 7 Anxiety, OCD, and Trauma-Related Disorders and Antianxiety Medication
Chapter 8 Psychotic Disorders and Antipsychotics
Part 3 Drugs of Abuse and Addiction
Chapter 9 Addiction: Diagnoses, Genetics, and Neurobiology
Chapter 10 Alcohol
Chapter 11 Nicotine
Chapter 12 Caffeine
Chapter 13 Stimulants – Cocaine and Amphetamines
Chapter 14 Opioids
Chapter 15 Hallucinogens
Chapter 16 Cannabis
James D. Calvert, Ph.D., MSCP has been a licensed clinical psychologist since 1990. After New Mexico and Louisiana passed laws licensing psychologists to prescribe medication, he obtained a post-doctoral master’s degree in clinical psychopharmacology and became licensed as a medical (prescribing) psychologist in 2007.He has spent over 30 years in healthcare as a practicing psychologist, program director, training director, clinical director, and executive director at community mental health agencies, hospitals, and private practices. He also taught psychology and organizational development at numerous universities, including Louisiana State University, University of Alabama, Birmingham-Southern College, Midwestern State University, and Southern Methodist University. He is currently senior lecturer at Southern Methodist University where he teaches psychopharmacology, childhood disorders, research methods, assessment, supervision, ethics, and other courses at both the undergraduate and doctoral levels. Dr. Calvert obtained his bachelor's degree from Clemson University and his Ph.D. in clinical psychology from Louisiana State University. He obtained a postdoctoral master’s degree in psychopharmacology from Fairleigh Dickinson University. He is a Fellow of the American Psychological Association in Divisions 55 (Pharmacotherapy), 53 (Child and Adolescent), and 43 (Couples and Family).